“It’s not exactly rocket science,” Ludek Sojka, CTO, SOTIO, admitted during our conversation on managing raw material supplier relationships to better control overall C&G therapy COGS. However, the past year has proven that securing a reliable supply of raw materials will — despite our best intentions — always be an evergreen challenge. A great reminder of this came in the form of a survey earlier this year revealing that dual-source supply chains — though they are regularly heralded as essential — still remain mythical for 50 percent of advanced therapy survey respondents.